BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Adalimumab
1
Three-year outcomes of tumor necrosis factor alpha inhibitor therapy in rheumatoid arthritis patients with elevated liver enzymes
7/25/2025 12:09:40 PM | Browse: 114 | Download: 582
2
Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review
3/18/2025 4:25:39 AM | Browse: 186 | Download: 661
3
Real-world experience and long-term outcomes of a mandatory non-medical switch of adalimumab originator to biosimilars in inflammatory bowel disease
11/21/2024 7:04:50 AM | Browse: 226 | Download: 998
4
Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis
2/25/2024 3:12:20 PM | Browse: 318 | Download: 1339
5
Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease
10/12/2023 10:39:02 AM | Browse: 292 | Download: 1004
6
Menstrual cycle abnormalities in women with inflammatory bowel disease and effects of biological therapy on gynecological pathology
7/27/2023 1:26:07 AM | Browse: 253 | Download: 1018
7
Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease
5/11/2023 8:05:04 AM | Browse: 378 | Download: 1025
8
Tislelizumab-related enteritis successfully treated with adalimumab: A case report
9/27/2022 1:00:17 PM | Browse: 418 | Download: 1433
9
Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
9/7/2022 8:29:04 AM | Browse: 805 | Download: 2459
10
Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
6/17/2022 3:19:26 AM | Browse: 711 | Download: 2181
11
Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
5/13/2022 8:46:12 AM | Browse: 643 | Download: 1740
12
Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study
3/3/2022 6:59:41 AM | Browse: 866 | Download: 2915
13
Predictive value of biologic blood concentration on endoscopic inactivity in inflammatory bowel disease: A systematic review
3/3/2021 10:02:01 AM | Browse: 908 | Download: 2463
14
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus
11/20/2020 4:04:17 AM | Browse: 1114 | Download: 2663
15
Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy
9/14/2017 3:13:08 AM | Browse: 1258 | Download: 1866
16
Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature
8/1/2017 12:23:47 AM | Browse: 1421 | Download: 2327
17
Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study
6/14/2017 9:25:57 AM | Browse: 1472 | Download: 2863
18
Combination therapy for inflammatory bowel disease
5/4/2017 8:16:34 AM | Browse: 1486 | Download: 2257
19
Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies
1/5/2017 11:10:00 AM | Browse: 1188 | Download: 2414
20
Adalimumab and pharmacokinetics: Impact on the clinical prescription for inflammatory bowel disease
3/4/2016 3:35:00 PM | Browse: 1385 | Download: 2318
21
Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases
6/29/2015 4:40:00 PM | Browse: 1494 | Download: 2813
22
Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody
6/11/2015 10:11:00 AM | Browse: 1381 | Download: 1951
23
Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease
2/11/2015 4:38:00 PM | Browse: 1338 | Download: 1952
24
Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review
9/16/2014 11:44:00 AM | Browse: 1297 | Download: 1068
25
Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients
9/16/2014 11:44:00 AM | Browse: 1363 | Download: 1794
26
Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease
9/16/2014 9:54:00 AM | Browse: 1448 | Download: 1425
27
Intestinal Behçet’s disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis
9/15/2014 8:53:00 PM | Browse: 1243 | Download: 1581
28
Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review
9/11/2014 8:40:00 PM | Browse: 1579 | Download: 1451
29
Severe cholestasis due to adalimumab in a Crohn’s disease patient
9/10/2014 5:06:00 PM | Browse: 1477 | Download: 1469
30
Therapeutic drug monitoring in patients with inflammatory bowel disease
8/29/2014 5:07:00 PM | Browse: 1405 | Download: 1650
31
TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: A case report and literature review
8/27/2014 5:15:00 PM | Browse: 1122 | Download: 1164
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.